The time of drug administration for both periods was considered as a reference for the study time (t = 0). The blood samples for PK measurements were drawn at 0 (pre-dose), 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 12, 18, 24, 30, 36, 48, 60, 72, and 96 h after dosing. Anticoagulant K2EDTA was added to blood samples and Na2HASO4 was added to prevent dephosphorylation of the DEX-P and BET-P phosphates in plasma. Plasma was separated from blood samples by centrifugation at 4 °C within 30 min after withdrawal. These samples were stored at − 70 °C before further analysis.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.